Cancer Biology and Therapeutics

Cancer Therapeutics and Metabolomics

Submit Abstract Register Now

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer. Despite the fact that new technologies and strategies often fail to identify well-established cancer biomarkers and show a bias toward the identification of high-abundance molecules, these technological advances have the capacity to revolutionize biomarker discovery.  Cancer immunotherapy (immuno-oncology) is the use of the immune system to treat cancer .The study of the tumor metabolism, also known as tumor metabolome describes the different characteristic metabolic changes in tumor cells. The emerging field of metabolomics – which attempts to profile all metabolites within a cell or biological system – is now being used to analyze cancer metabolism on a system-wide scale, painting a broad picture of the altered pathways and their interactions with each other. While a large fraction of cancer metabolomics research is focused on finding diagnostic biomarkers, metabolomics is also being used to obtain more fundamental mechanistic insight into cancer and carcinogenesis.This Session Includes Current Trends and Innovations in Metabolomics, Molecular cancer therapeutics, Clinical and potential applications of metabolomics in oncology, Metabolomics in novel biomarker discovery, Revisiting tumor metabolism, Telomerase: A target for cancer therapeutics, Analytical and bio-analytical techniques in metabolomics, Transcriptomics, Toxicology and drug metabolism.For More Information please, CLICK HERE